Posted
Clinical trials, notably funded by the Telethon, are raising the hopes of many people with rare diseases. Professor Christelle Monville, researcher at I-Stem, was the guest of the 11 p.m. from franceinfo, Friday December 3.
People with rare diseases are participating in clinical trials in the hope of a cure one day, but also to help research and future generations. Professor Christelle Monville, researcher at I-Stem, the stem cell institute for the treatment and study of monogenic diseases, followed, with other researchers, Adrien Maaninou, suffering from a degenerative disease of vision and who benefited from a cell therapy trial thanks to the Telethon. “There is still a little light for Adrien and we hope that with the patch he received, he will be able to keep this light, because the idea is to stop the progression of his disease.“, she explains on the 11pm set, Friday December 3.
Christelle Monville heads a team working on retinal pathologies. “We developed a small patch from stem cells, we made retinal cells that we placed on a small membrane (…). It’s a patch that we put under the retina“, describes the professor, specifying that, for the moment,”we are not able to give back the sight“. The development of this patch also required ten years of work. The team received, from the start, the support of the AFM Telethon.”AFM allows the acceleration of medicine, but we must continue, there is still progress to be made“, she concludes.